Coronavirus | Global Biodefense

Menu

Latest stories

Middle Eastern Respiratory Syndrome virus particles

Adaptive Evolution of MERS-CoV to Infect Different Species

MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments

More on pathogens and preparedness

Experimental MERS Antibody Therapeutics Enter Clinical Trial

by Global Biodefense May 18, 2018, 7:33 am
BARDA Backs Antibody Therapy Against MERS Virus

by Global Biodefense August 22, 2016, 8:46 pm
First-In-Human Study of MERS Vaccine Completes Enrollment
NIH Evaluating New Antibody Treatment for MERS-CoV

by Global Biodefense August 11, 2016, 6:24 pm
MERS-CoV Less Virulent During Outbreak?

by Global Biodefense March 7, 2016, 7:47 am
MERS-CoV Likely Began in Bats, Moved to Camels, Then People

by Global Biodefense March 1, 2016, 12:03 pm
Walter Reed Kicks Off Phase 1 MERS Vaccine Trial
Inovio and GeneOne Kick Off MERS Vaccine Trial

by Global Biodefense February 1, 2016, 9:10 am
Report Outlines Framework for Global Pandemic Preparedness

by Global Biodefense January 13, 2016, 9:42 am
New Vaccine Against MERS Tested on Dromedary Camels

by Global Biodefense December 18, 2015, 10:13 am
Rapid Medical Countermeasure Response to Infectious Diseases
Kenya: MERS Virus Widespread in Camels

by Global Biodefense October 19, 2015, 8:09 am

Congratulations. You've reached the end of the internet.

Back to Top

Close